Verzögert
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
2’169 INR | +1.96% | +2.09% | +9.46% |
30.05. | Advent International erhält 6-7 Gebote für Bharat Serums | CI |
16.05. | Transcript : Mankind Pharma Limited, Q4 2024 Earnings Call, May 16, 2024 |
Kurzporträt
Mitarbeiterzahl: 18 468
Umsatz nach Geschäftsbereich
INR in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
Pharmaceuticals and Other related Products
100,0
%
| 77 816 | 100,0 % | 87 494 | 100,0 % | +12.44% |
Umsatz je Region
INR in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
India
96,6
%
| 75 947 | 97,6 % | 84 470 | 96,6 % | +11.22% |
International
3,4
%
| 1 868 | 2,4 % | 2 958 | 3,4 % | +58.36% |
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Sheetal Arora
CEO | Chief Executive Officer | 48 | 21.09.07 |
Ashutosh Dhawan
DFI | Director of Finance/CFO | 55 | 17.06.16 |
Pradeep Chugh
CMP | Compliance Officer | - | 23.09.16 |
Pramod Gokhale
CTO | Chief Tech/Sci/R&D Officer | - | 14.05.10 |
Anil Kumar
CTO | Chief Tech/Sci/R&D Officer | - | 01.12.11 |
Chanakya Juneja
CTO | Chief Tech/Sci/R&D Officer | - | 15.11.19 |
Arjun Juneja
COO | Chief Operating Officer | - | 15.05.09 |
Rajeev Juneja
BRD | Director/Board Member | 58 | 22.12.92 |
Investor Relations Contact | - | - | |
Akshay Bansal
PRN | Corporate Officer/Principal | 50 | - |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Vivek Kalra
BRD | Director/Board Member | 60 | 01.08.22 |
Vijaya Sampath
BRD | Director/Board Member | 71 | 01.08.22 |
Surendra Lunia
BRD | Director/Board Member | 61 | 19.02.15 |
Founder | 68 | 01.01.86 | |
Rajeev Juneja
BRD | Director/Board Member | 58 | 22.12.92 |
Sheetal Arora
CEO | Chief Executive Officer | 48 | 21.09.07 |
Director/Board Member | 69 | 01.01.20 | |
Bharat Anand
BRD | Director/Board Member | 47 | 31.08.18 |
Arjun Juneja
COO | Chief Operating Officer | - | 15.05.09 |
Director/Board Member | 51 | 23.09.16 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 400 635 138 | 79 794 441 ( 19,92 %) | 0 | 19,92 % |
Unternehmenskontakt
Mankind Pharma Ltd.
262, Okhla Industrial Estate Phase-III
110020, New Delhi
+91 11 4654 1111
http://www.mankindpharma.comKonzerngesellschaften
Name | Kategorie und Branche |
---|---|
PackTime Innovations Pvt Ltd.
| |
Copmed Pharmaceuticals Pvt Ltd.
|
Sektor
Umsatz je Region
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
+9.46% | 10.21 Mrd. | |
+45.82% | 765 Mrd. | |
-6.16% | 354 Mrd. | |
+19.86% | 331 Mrd. | |
+9.32% | 299 Mrd. | |
+18.81% | 248 Mrd. | |
-1.92% | 219 Mrd. | |
+10.85% | 216 Mrd. | |
+5.90% | 164 Mrd. | |
-0.73% | 162 Mrd. |
- Börse
- Aktien
- A3EFQV Aktie
- Unternehmen Mankind Pharma Limited